Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,565
Closed -$723K 415
2026
Q1
$723K Sell
9,565
-4,399
-32% -$331K 0.01% 254
2025
Q4
$1.04M Sell
13,964
-775
-5% -$56.6K 0.02% 241
2025
Q3
$995K Sell
14,739
-7,203
-33% -$478K 0.01% 261
2025
Q2
$1.43M Hold
21,942
0.02% 231
2025
Q1
$1.35M Sell
21,942
-32,272
-60% -$2.14M 0.03% 225
2024
Q4
$3.92M Buy
54,214
+21,037
+63% +$1.64M 0.08% 131
2024
Q3
$2.17M Buy
33,177
+2,999
+10% +$240K 0.06% 170
2024
Q2
$2.24M Sell
30,178
-6,303
-17% -$472K 0.03% 202
2024
Q1
$2.84M Buy
36,481
+1,029
+3% +$76.5K 0.05% 192
2023
Q4
$2.53M Buy
+35,452
New +$2.47M 0.07% 182

Other funds holding HOLX

Groupama Asset Management's HOLX Position: Q2 2026 in Review

Groupama Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 9,565 shares — an estimated $723K sold.

Groupama Asset Management first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $3.92M in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Groupama Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Groupama Asset Management sold 9,565 Hologic shares in Q2 2026, an estimated $723K.
  • Groupama Asset Management first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • Groupama Asset Management's Hologic position peaked at $3.92M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.